Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2007
11/29/2007CA2646076A1 3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/28/2007EP1860100A2 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI
11/28/2007EP1859798A1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
11/28/2007EP1858884A1 Indazolylamino quinazoline derivatives as antitumor agents
11/28/2007EP1858862A1 PYRAZINE -2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS
11/28/2007EP1725543B1 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
11/28/2007EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
11/28/2007CN101080405A Quaternary ammonium salts as M3 antagonists
11/28/2007CN101080403A Novel hydantoin derivatives as metalloproteinase inhibitors
11/28/2007CN101080401A Substituted biaryl analogues
11/28/2007CN101080396A Quinoxalines as B Raf inhibitors
11/28/2007CN101080226A Amido compounds and their use as pharmaceuticals
11/28/2007CN101077865A Phthalazines derivatives, preparation method thereof, medicament composition and use
11/28/2007CN100351251C Indolylmaleimide derivatives
11/28/2007CN100351249C Quinolinone derivatives as tyrosine kinase inhibitors
11/28/2007CN100351243C Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones
11/28/2007CN100351242C Processes and intermediates for preparing anti-cancer compounds
11/28/2007CN100351239C Pyrimidine derivatives and their use as CB2 modulators
11/28/2007CN100351236C 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
11/28/2007CN100351235C 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composi
11/28/2007CN100351230C Urea of N-heterocyclic carboxylic acid or the isostere of carboxylic acid and aminocarboxylic acid ester
11/27/2007US7301036 Methyl 4-[(3-methyl-4-methylsufonyl-2-{[4-(trifluoromethoxy)-phenyl]imino}-6-(trifluoromethyl)-2,3-dihydro-1H-benzimidazol-1-yl)methyl]benzoate; glucagon receptor antagonists; type 2 diabetes mellitus
11/27/2007US7301035 Intermediates for the synthesis of irbesartan
11/27/2007US7301022 N-(2-(6-7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-ylamino)pyrimidin-4-yl)-5-(trifluoromethyl)phenyl)-1-isopropylpyrrolidine-2-carboxamide hydrochloride; antiinflammatory agents, analgesics, antiarthritic agents, antiulcer agents
11/27/2007US7301021 Substituted imidazole compounds
11/27/2007US7300950 Pyrazole derivatives, their preparation and their use in pharmaceuticals
11/27/2007US7300947 N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives
11/27/2007US7300945 For therapy of of certain central nervous system (CNS) diseases, anxiety, depression, a sleep disorder, schizophrenia, or attention deficit-hyperactivity disorder
11/27/2007US7300937 Derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
11/27/2007US7300936 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
11/27/2007US7300933 Diazabicyclic biaryl derivatives
11/27/2007CA2400377C Method for treating ocular pain
11/27/2007CA2358998C Substituted bicyclic derivatives useful as anticancer agents
11/22/2007WO2007133040A1 Method for preparing losartan
11/22/2007WO2007132227A1 Maleate co-crystal of azd1152
11/22/2007WO2007131764A2 New heterocyclic compounds for the inhibition of integrins and use thereof
11/22/2007WO2007131366A1 Iap bir domain binding compounds
11/22/2007WO2007120595A3 Amines for the treatment of hcv
11/22/2007WO2007109330A3 S1p receptor modulating compounds
11/22/2007WO2007095495A3 Benzodiazepine gcnf modulators for stem cell modulation
11/22/2007WO2007077961A3 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands
11/22/2007WO2006099268A3 Cgrp receptor antagonists
11/22/2007WO2006049835A3 Indole and benzimidazole derivatives
11/22/2007US20070270478 e.g. 3-[4-(3,5-bis-trifluoromethyl-pyrazol-1-yl)-phenyl]-2-(2,3-difluoro-phenyl)-acrylonitrile; immunosuppressant; bioavailability; side effect reduction; interleukin-2 inhibitor
11/22/2007US20070270474 Pyrazole compounds for treatment of neurodegenerative disorders
11/22/2007US20070270444 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
11/22/2007US20070270436 Novel amino- and imino-alkylpiperazines
11/22/2007US20070270427 vascular endothelial growth factor receptor inhibitors such as N2-(3-methyl-1H-indazol-6-yl)-N4-{3-[(methylsulfonyl)methyl]phenyl}-1,3,5-triazine-2,4-diamine trifluoroacetate, used as anticarcinogenic, antitumor or antiproliferative agents
11/22/2007US20070270424 Heterocyclic inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1 and methods of using the same
11/22/2007US20070270423 Histamine 3 receptor antagonists/inverse agonists ; (4-isopropyl-piperazin-1-yl)-[1-(1-isopropyl-pyrrolidin-3-yl)-1H-indol-5-yl]-methanone; obesity, metabolic syndrome (syndrome X), and other eating disorders
11/22/2007US20070270421 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
11/22/2007US20070270420 Heteroaryl compounds useful as inhibitors of gsk-3
11/22/2007US20070270412 Novel pharmaceuticals
11/22/2007US20070270411 Novel Diazepine Compounds as Ligands of the Melanocortin 1 and/or 4 Receptors
11/22/2007US20070270400 New compounds 303
11/22/2007US20070270398 New Compounds III
11/22/2007US20070267968 Electronic devices made with electron transport and/or anti-quenching layers
11/22/2007CA2652455A1 Iap bir domain binding compounds
11/22/2007CA2652101A1 New heterocyclic compounds for the inhibition of integrins and use thereof
11/22/2007CA2650519A1 Maleate co-crystal of azd1152
11/21/2007EP1857442A2 Novel antimycobacterial compounds
11/21/2007EP1856107A1 Pyrrolidine and piperidine acetylene derivatives for use as mglur5 antagonists
11/21/2007EP1856105A1 Quinoxaline dihydrohalide dihydrates and synthetic methods therefor
11/21/2007EP1856104A1 Processes and compounds for the preparation of substituted naphthylindole derivatives
11/21/2007EP1856103A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
11/21/2007EP1856102A1 Medicaments for alzheimer
11/21/2007EP1856064A2 A process for the preparation of melamine cyanurate
11/21/2007EP1856063A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
11/21/2007EP1856059A2 Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors
11/21/2007EP1856058A2 Phthalazine, aza- and diaza-phthalazine compounds and methods of use
11/21/2007EP1856056A1 Phenoxy benzamide compounds with utility in the treatment of type 2 diabetes and obesity
11/21/2007EP1856045A1 1-acetic acid-indole derivatives with pgd2 antagonist activity
11/21/2007EP1855670A2 Benzazole potentiators of metabotropic glutamate receptors
11/21/2007EP1474135B1 Indole, azaindole and related heterocyclic pyrrolidine derivatives
11/21/2007EP1458383B1 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
11/21/2007EP1197226B1 Agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof
11/21/2007EP1150996B1 New amidinobenzylamine derivatives and their use as thrombin inhibitors
11/21/2007CN101076528A Organic compound, charge transport material and organic electroluminescent element
11/21/2007CN101076527A Tricyclic anilide spirohydantoin cgrp receptor antagonists
11/21/2007CN101074242A Cells accumulation for sphosphonate analogs of HIV protease inhibitor compound and the same compound
11/21/2007CN101074238A Heterocyclic boronic acid compounds
11/21/2007CN101074227A Phosphine acyloxy quinazoline derivatives and their medicine using
11/21/2007CN101074210A Pharmaceutically active isoindoline derivatives
11/21/2007CN100349890C Quinazoline(di) ones for invertebrate pest control
11/21/2007CN100349874C Novel compounds
11/20/2007US7297797 5-(2,6-difluorophenyl)-2-[4'-(5-ethoxy-2-thienyl)-1,1'-biphenyl-4-yl]-3,4-dihydro-2H-pyrrole; pesticide
11/20/2007US7297711 Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
11/20/2007US7297701 Anti-cancer cyclopenta [G]quinazoline compounds
11/20/2007US7297698 e.g. (2R,5S)-4-(3-chloro-4-cyanophenyl)-N-(2-cyclopropylpyrimidin-5-yl)-2,5-dimethylpiperazine-1-carboxamide; antiandrogenic agent
11/20/2007US7297692 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
11/20/2007CA2139374C Polyaminated ligands and metal complexes thereof
11/20/2007CA2125236C Fungicidal optically active 2-imidazolin-5-one and 2-imidazoline-5-thione derivatives
11/15/2007WO2007131016A2 Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
11/15/2007WO2007130822A2 Mglur5 modulators iii
11/15/2007WO2007130780A2 Benzimidazole modulators of vr1
11/15/2007WO2007130676A2 Gas generant compositions
11/15/2007WO2007130616A2 Polyamides for treating human papilloma virus
11/15/2007WO2007129963A1 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
11/15/2007WO2007129745A1 Heteroarylamide lower carboxylic acid derivative
11/15/2007WO2007129473A1 Bicyclic aryl derivative
1 ... 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 ... 626